SK

Simranjeet Kaur

Active Director Director DIN 09124231
DIN 09124231 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Simranjeet Kaur

Data last updated:

Simranjeet Kaur is a Director at Nlh Health Care Private Limited (since 2021). The company operates in Healthcare. Nlh Health Care Private Limited reported revenue of ₹5.95 Cr (FY 2024).

DIN 09124231
Primary Designation Director
Industry Healthcare
First Appointment 25 Mar 2021
Oldest Company Age 5 yrs
Largest company Nlh Health Care Private Limited · ₹5.95 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nlh Health Care Private Limited U85100PB2021PTC053103
Director25 Mar 20212021₹5.95 Cr (FY 2024)Active

Board colleagues of Simranjeet Kaur

Directorship timeline

Open interactive timeline →
Nlh Health Care Private Limited
Premium access

Shareholding and investment profile for Simranjeet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Simranjeet Kaur

Simranjeet Kaur currently holds 1 directorship: Nlh Health Care Private Limited (Director, since 25 Mar 2021, revenue ₹5.95 Cr (FY 2024)).

Simranjeet Kaur was first appointed on 25 Mar 2021 as Director at Nlh Health Care Private Limited.

The current boards of Simranjeet Kaur's companies include Himanshu Rai (Nlh Health Care Private Limited), Simranjit Singh (Nlh Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available